View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/FDA | RIN: 0910-AF12 | Publication ID: Spring 2006 |
Title: Cochineal Extract and Carmine Label Declaration | |
Abstract: The purpose of this proposed rule is to protect consumers who have allergies to the color additives carmine and cochineal extract by requiring label declaration on products under FDA jurisdiction. This action responds to adverse event reports received by FDA and to a citizen petition submitted to FDA. | |
Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 21 CFR 73.100(d) 21 CFR 73.2087(c) 21 CFR 101.22(k) | |
Legal Authority: 21 USC 379e(b) |
Legal Deadline:
None |
|||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Yes | Government Levels Affected: None |
Small Entities Affected: Businesses | Federalism: No |
Included in the Regulatory Plan: No | |
Agency Contact: Mical E. Honigfort Consumer Safety Officer Department of Health and Human Services Food and Drug Administration HFS-265, 5100 Paint Branch Parkway, College Park, MD 20740 Phone:301 436-1278 Fax:301 436-2972 Email: mical.honigfort@fda.hhs.gov |